IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Silexion Therapeutics Corp

CUSIP: G1281K114 | 39 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AIntracoastal Capital LLC00.0%No shares heldJun 30, 2026No 13F filer matched
13G/AIntracoastal Capital LLC0
0.0% of class · Jun 30, 2026

Institutional Holders — Q3 2026

Security Benefit Life Insurance Co150,000
0.0% of portfolio›$1.4K
Context Capital Management, LLC51,183
0.0% of portfolio›$261
Dupont Capital Management Corp32,500
0.0% of portfolio›$306
StyleTurnoverLocationFiled
Security Benefit Life Insurance Co
150,000$1.4K0.0%Agg GrowthMediumTopeka, KS2026-11-05
Context Capital Management, LLC
51,183$2610.0%GARPHighGreenwich, CT2026-11-04
Dupont Capital Management Corp
32,500$3060.0%GARPLowWilmington, DE2026-10-23
No shares held
No 13F filer matched